Merck & Co., Inc. Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated, Amount (Deprecated 2011-01-31)
Merck & Co., Inc. (MRK) reported Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated, Amount (Deprecated 2011-01-31) of $39.30 million for the 3-month period ending 2010-09-30, per its 10-Q filed 2010-11-08.
Discontinued › Notes
us-gaap:SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedAmount · last filed 2010-11-08
- Merck & Co., Inc. segment reporting, reconciling item for operating profit (loss) from segment to consolidated, amount (deprecated 2011-01-31) for the quarter ending 2010-09-30 was $39.30M, a 48.83% decline year-over-year.
- Merck & Co., Inc. segment reporting, reconciling item for operating profit (loss) from segment to consolidated, amount (deprecated 2011-01-31) for the quarter ending 2010-06-30 was $87.40M, a 5.00% decline year-over-year.
- Merck & Co., Inc. segment reporting, reconciling item for operating profit (loss) from segment to consolidated, amount (deprecated 2011-01-31) for the quarter ending 2009-09-30 was $76.80M.
- Merck & Co., Inc. segment reporting, reconciling item for operating profit (loss) from segment to consolidated, amount (deprecated 2011-01-31) for the quarter ending 2009-06-30 was $92.00M.
| Period end | Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated, Amount (Deprecated 2011-01-31) 3 month | Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated, Amount (Deprecated 2011-01-31) 6 month | Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated, Amount (Deprecated 2011-01-31) 9 month |
|---|---|---|---|
| 2010-09-30 | $39.30M 10-Q · filed 2010-11-08 | $126.70M derived: sum of 2 quarters · filed 2010-11-08 | $214.10M 10-Q · filed 2010-11-08 |
| 2010-06-30 | $87.40M 10-Q · filed 2010-08-06 | $174.60M 10-Q · filed 2010-08-06 | |
| 2009-09-30 | $76.80M 10-Q · filed 2010-11-08 | $168.80M derived: sum of 2 quarters · filed 2010-11-08 | $256.20M 10-Q · filed 2010-11-08 |
| 2009-06-30 | $92.00M 10-Q · filed 2010-08-06 | $179.40M 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |